Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
Adekile A, Kutlar F, McKie K, Addington A, Elam D, Holley L, Clair B, Kutlar A. Adekile A, et al. Among authors: kutlar f, kutlar a. Eur J Haematol. 2005 Aug;75(2):150-5. doi: 10.1111/j.1600-0609.2005.00477.x. Eur J Haematol. 2005. PMID: 16004608
The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.
Smith WR, Ballas SK, McCarthy WF, Bauserman RL, Swerdlow PS, Steinberg MH, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Smith WR, et al. Pain Med. 2011 May;12(5):697-705. doi: 10.1111/j.1526-4637.2011.01096.x. Epub 2011 Apr 11. Pain Med. 2011. PMID: 21481164 Free PMC article. Clinical Trial.
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. Steinberg MH, et al. Among authors: kutlar a. Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699. Am J Hematol. 2010. PMID: 20513116 Free PMC article. Clinical Trial.
Postmortem molecular diagnosis of sickle beta thalassaemia.
Kutlar F, Mirmow D, Glendenning M, Holley L, Kutlar A. Kutlar F, et al. Among authors: kutlar a. J Clin Pathol. 2005 May;58(5):548-9. doi: 10.1136/jcp.2004.018127. J Clin Pathol. 2005. PMID: 15858131 Free PMC article.
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.
Orringer EP, Casella JF, Ataga KI, Koshy M, Adams-Graves P, Luchtman-Jones L, Wun T, Watanabe M, Shafer F, Kutlar A, Abboud M, Steinberg M, Adler B, Swerdlow P, Terregino C, Saccente S, Files B, Ballas S, Brown R, Wojtowicz-Praga S, Grindel JM. Orringer EP, et al. Among authors: kutlar a. JAMA. 2001 Nov 7;286(17):2099-106. doi: 10.1001/jama.286.17.2099. JAMA. 2001. PMID: 11694150 Clinical Trial.
The M gamma chain of human fetal hemoglobin.
Huisman TH, Kutlar F, Kutlar A, Wilson JB, Harris HF. Huisman TH, et al. Among authors: kutlar f, kutlar a. Prog Clin Biol Res. 1987;251:507-17. Prog Clin Biol Res. 1987. PMID: 2448816
266 results